Abstract |
Epstein-Barr Virus latent membrane protein-1 (LMP1) interacts with the SUMO-conjugating enzyme Ubc9, which induces protein sumoylation and may contribute to LMP1-mediated oncogenesis. After analyzing human lymphoma tissues and EBV-positive cell lines, we now document a strong correlation between LMP1 and sumo-1/2/3 or SUMO-1/2/3 levels, and show that LMP1-induced sumo expression requires the activation of NF-κB signaling through CTAR1 and CTAR2. Together, these results point to a second mechanism by which LMP1 dysregulates sumoylation processes and adds EBV-associated lymphomas to the list of malignancies associated with increased SUMO expression.
|
Authors | Sadia Salahuddin, Emma K Fath, Natalie Biel, Ashley Ray, C Randall Moss, Akash Patel, Sheetal Patel, Leslie Hilding, Matthew Varn, Tabithia Ross, Wyatt T Cramblet, Angela Lowrey, Joseph S Pagano, Julia Shackelford, Gretchen L Bentz |
Journal | Scientific reports
(Sci Rep)
Vol. 9
Issue 1
Pg. 208
(01 18 2019)
ISSN: 2045-2322 [Electronic] England |
PMID | 30659232
(Publication Type: Journal Article, Research Support, N.I.H., Extramural)
|
Chemical References |
- EBV-associated membrane antigen, Epstein-Barr virus
- Membrane Proteins
- NF-kappa B
- SUMO-1 Protein
- SUMO2 protein, human
- SUMO3 protein, human
- Small Ubiquitin-Related Modifier Proteins
- Ubiquitins
- Viral Matrix Proteins
- Ubiquitin-Conjugating Enzymes
- ubiquitin-conjugating enzyme UBC9
|
Topics |
- Cell Line
- HEK293 Cells
- Herpesvirus 4, Human
(metabolism)
- Humans
- Lymphoma
(metabolism)
- Membrane Proteins
(metabolism)
- NF-kappa B
(metabolism)
- Protein Binding
- SUMO-1 Protein
(genetics, metabolism)
- Signal Transduction
- Small Ubiquitin-Related Modifier Proteins
(genetics, metabolism)
- Sumoylation
- Ubiquitin-Conjugating Enzymes
(metabolism)
- Ubiquitins
(metabolism)
- Viral Matrix Proteins
(metabolism, physiology)
|